Correction to: Oral Cancer Immunotherapy through a Simvastatin-Loaded Colloidal Dispersion System for the Generation of Sustained Antitumor Immunity (Adv. Therap, (2021), 4, (2100025), 10.1002/10.1002/adtp.202100025)

https://doi.org/10.1002/adtp.202100025 Adv. Therap. 2021, 4, 2100025 The authors are correcting this article because they accidentally included a mistake in figure 2C. These errors do not affect the results or conclusions of the paper. The authors sincerely apologize for any confusion this may have caused. In Figure 2C, the confocal images of two comparison groups (i.e., Coumarin-6-co-loaded SIMVA in water and Coumarin-6-co-loaded SIMVA in 5% DMSO) were repeated. Figure 2C represents cellular uptakes of Coumarin-6-co-loaded simvastatin (SIMVA) formulations though the ASBT-unexpressed MDCK cells which were indirectly measured qualitive data by detecting Coumarin-6 in the various SIMVA formulations in order to support the quantitative data (Figure 2E, F). In addition, this unrecognized error was occurred between the comparison groups, not in the formulation groups, which might be caused by wrong attachment of the images while organizing the subfigures in Figure 2 due to the similarity of results between these two groups. The correct figure 2C is as follow:.